|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit (loss) | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General, administrative and marketing | |||||
| Total operating loss | |||||
| Financial income (expenses), net | |||||
| Net loss | |||||
| Basic net loss per ordinary share (in Dollars per share) | |||||
| Diluted net loss per ordinary share (in Dollars per share) | |||||
| Weighted average number of ordinary shares used in computation of basic net loss per share (in Shares) | |||||
| Weighted average number of ordinary shares used in computation of diluted net loss per share (in Shares) |
Loading...
